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Abstract
Background: A retrospective study was designed to investigate P-wave duration changes in exercise 
stress test (EST) for the prediction of angiographically documented substantial coronary artery disease 
(CAD).
Methods: We analyzed 265 cases of patients, who underwent EST and subsequently coronary angio-
graphy. Analysis of P-wave duration was performed in leads II, V5 at rest, and in the recovery period.
Results: The sensitivity and specificity for the isolated ST-segment depression were only 31% and 76%, 
respectively. The combination of ST-depression with other exercise-induced clinical and electrocardio-
graphic abnormalities (chest pain, ventricular arrhythmia, hypotension, left bundle branch block) was 
characterized by 41% sensitivity and 69% specificity. The combination of abnormal recovery P-wave 
duration (≥ 120 ms) with ST-depression and other exercise-induced abnormalities had 83% sensitivity 
but only 20% specificity. Combined analysis of increased delta P-wave duration, ST-depression and 
other exercise-induced abnormalities had 69% sensitivity and 42% specificity. Sensitivity and specificity 
of the increase in delta P-wave duration for left CAD was 69% and 47%, respectively, and for 3-vessel 
CAD 70% and 50%, respectively. The presence of arterial hypertension negatively influenced the prog-
nostic value of P-wave changes in the stress test.
Conclusions: The results of the study show that an addition of P-wave duration changes assessment to 
ST-depression analysis and other exercise-induced abnormalities increase sensitivity of EST, especially 
for left CAD and 3-vessel coronary disease. We have also provided evidence for the negative influence of 
the presence of arterial hypertension on the predictive value of P-wave changes in the stress test. (Cardiol J  
2017; 24, 2: 159–166)
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Introduction
An analysis of the ST-segment during exercise 
stress test (EST) is an acknowledged method for 
myocardial ischemia detection with sensitivity and 
specificity for coronary disease up to 50% and 90%, 
respectively [1–3]. According to current guide-
lines for the diagnosis of stable coronary artery 
disease (CAD), EST is recommended, especially 
for intermediate-risk patients [1–4].
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The assessment of P-wave parameters is a sub- 
stantial element of both resting and stress electro-
cardiography. The prolongation and inhomogene-
ous propagation of electrical impulses through the 
muscle of the atrial wall with subsequent changes 
of the P-wave duration (PWD) and P-wave disper-
sion were found to increase the risk of paroxysmal 
and recurrent atrial fibrillation [5, 6]. Chronic ar-
terial hypertension results in left atrium enlarge-
ment and left ventricular (LV) hypertrophy and, 
in effect, was shown to widen P-wave ≥ 120 ms 
on electrocardiographic tracings [7]. An increased 
amount of data also provides evidence for PWD and 
dispersion changes in obesity and in patients with 
chronic obstructive sleep syndrome [8, 9].
In several studies, widened P-wave was re-
garded as an easily quantifiable morphophysi-
ologic parameter of LV diastolic dysfunction and 
an early marker of myocardial ischemia [10, 11]. 
Myrianthefs et al. [12] reported that during coro-
nary angioplasty P-wave dispersion was higher 
and correlated with the severity of the coronary 
artery stenosis. This thesis was supported by other 
authors [13–15]. To date, the usefulness of P-wave 
parameters as an identification of ischemia during 
EST has been assessed in only a few observations.
The objective of the present study was to 
assess the significance of the estimation of PWD 
in EST for the prediction of substantial coronary 
stenoses documented by coronary angiography. 
Based on the abovementioned data, the study was 
also planned to discover whether the presence 
of arterial hypertension and obesity affects EST 
PWD duration changes and how the presence of 
these comorbidities changes the predictive value 
of P-wave parameters for CAD diagnosis.
Methods
For the present study, we retrospectively 
enrolled a cohort of 265 patients (inpatients; 177 
male; mean age: 60.75 ± 9.9 years), who from 
2009 to 2011 underwent exercise stress tests for 
CAD diagnosis and subsequently, but not longer 
than 6 months later, coronary angiography in the 
Department of Cardiology, Brodnowski Hospital. 
The experimental protocol was approved by the 
Human Research Ethics Committee of the Warsaw 
Medical University (KB/191/2012). Patients with 
any of the following were excluded from the study: 
a medical history of atrial fibrillation, with a pace-
maker rhythm, atrioventricular or intraventricular 
conduction disturbances (except from the left bun-
dle branch block [LBBB] that appeared on EST), 
or significant motion artifacts in the electrocardio­
graphy that made it impossible to estimate P-wave 
parameters precisely. Demographic and clinical 
data were obtained from the medical histories of 
patients and the database in the Ergometry Labo-
ratory. The following information was noted: age, 
gender, weight, height, arterial hypertension, rest-
ing transthoracic echocardiographic parameters 
(ejection fraction, the LV diastolic diameter, the 
presence of LV hypertrophy), and current pharma-
cotherapy. Body mass index (BMI) was calculated 
as the ratio of weight in kilograms divided by the 
square of height in meters.
A treadmill exercise stress test was performed 
in the presence of an experienced physician using 
a GE CASE Version 6.1 (GE Medical Systems, 
Freiburg, Germany) and the Bruce protocol was 
applied for all patients [16]. The test was de-
scribed as “ischemic” according to the presence 
of acknowledged clinical and electrocardiographic 
abnormalities, such as chest pain, horizontal or 
downsloping ST-segment depression ≥ 0.10 mV 
(1 mm) or ST-segment elevation ≥ 1 mm at the 
J point plus 60 ms, emergence of ventricular ar-
rhythmia, exercise-induced hypotension, exercise-
induced LBBB at a heart rate < 125 bpm [17].
An analysis of PWD was performed, accord-
ing to the procedure described above, at resting 
conditions (resting PWD) and in the first minute 
of the recovery period (recovery PWD) when 
the heart rate was < 140 bpm, while the patient 
was standing on the treadmill, according to the 
protocol described before [14, 16]. PWD was 
recognized as abnormal when PWD ≥ 120 ms. 
All electrocardiograms were recorded with a speed 
of 25 mm/s and with an amplitude of 1 mV/cm. 
Changes in the P-wave parameters were estimated 
(computer-assisted assessment) in leads II and V5 
by two independent investigators blinded to the 
results of both EST and coronary angiography 
according to the procedure described previously 
by Maganis et al. [18]. Intraobserver differences 
in the estimation of the P-wave parameters were 
not higher than 4%. The change in PWD (DPWD) 
was estimated as PWDrecovery – PWDresting. The 
measurements of the PWD were performed with 
a 4­fold magnification of the tracings (100 mm/s, 
40 mm/mV).
All the patients were scheduled by their at-
tending cardiologist and underwent coronary angi-
ography not later than 6 months after EST. Images 
were recorded in multiple projections for left and 
right coronary arteries using a Philips Allura FD10 
Flat Panel System (Philips Healthcare, Nether-
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lands). The interpretation of all the angiograms 
was made visually by experienced, certified (Pol-
ish Cardiac Society) interventional cardiologists. 
Significant coronary stenosis (coronary stenosis 
group) was defined as > 50% narrowing of vessel 
lumen.
Statistical analysis
All data were analyzed using Statistica Version 
10 (Statsoft, Tulsa, United States of America). The 
differences were considered significant if p < 0.05. 
Continuous variables presented in text, tables and 
figures are means ± standard errors. Categori-
cal variables are shown in absolute numbers and 
percentages. For the comparison of the qualitative 
data the c2 test was used. One-way analysis of vari-
ance was used to detect significant differences in 
changes of the measured parameters between the 
patients in the study groups (patients with ischemic 
EST results and non-ischemic EST results). The 
horizontal and vertical multiple pair-wise compari-
sons were made by means of the post hoc Tukey’s 
test. Associations of P-wave measurements with 
clinical variables were assessed by the Pearson’s 
correlation coefficient.
Results
Clinical and demographic characteristic  
of the study population
Baseline demographic and clinical characteris-
tics of the study population in respect of the results 
of the coronary angiography are presented in Table 1. 
Coronary angiography revealed 156 patients with 
no significant coronary stenoses (non­coronary 
stenosis group) and 109 patients with the presence 
of significant coronary lesions (coronary stenosis 
group). In the coronary stenosis group, 31 (28.4%) 
patients had 1­vessel disease, 46 (42.2%) patients 
had 2­vessel disease, and 32 (29.4%) patients had 
Table 1. Demographic and clinical characteristics of the study population in respect of the coronary 
angiography result; means ± standard errors are shown.
Parameter Coronary angiography F; p value
Non-coronary stenosis 
group (n = 156)
Coronary stenosis  
group (n = 109)
Male 104 (67%) 73 (67%) NS
Arterial hypertension 89 (57%) 54 (50%) NS
Left ventricular hypertrophy 82 (53%) 51 (47%) NS
Medical treatment:
Beta-blockers 112 (72%) 77 (71%) NS
ACE-inhibitors 102 (65%) 66 (61%) NS
Statins 104 (67%) 73 (67%) NS
Acetylsalicylic acid 105 (67%) 77 (71%) NS
P2Y12 inhibitors 64 (41%) 40 (37%) NS
Age 60 ± 0.85 63 ± 0.81 F(1, 263) = 6.023,  
p < 0.05
Body mass index 29 ± 0.38 28 ± 0.41 NS
Ejection fraction [%] 56 ± 0.72 55 ± 1.01 NS
Max. ST-deviation [mV] –0.08 ± 0.01 –0.09 ± 0.01 NS
Resting PWDII [ms] 110 ± 1.02 113 ± 1.96 NS
Resting PWDV5 [ms] 107 ± 1.02 110 ± 1.82 NS
Recovery PWDII [ms] 116 ± 1.29 121 ± 2.26 F(1, 263) = 4.055,  
p < 0.05
Recovery PWDV5 [ms] 113 ± 1.29 119 ± 2.25 F(1, 263) = 4.369,  
p < 0.05
DPWDII [ms] 6.87 ± 1.13 8.15 ± 1.12 F(1, 263)= 3.432,  
p < 0.05
DPWDV5 [ms] 6.51 ± 1.15 8.25 ± 1.53 F(1, 263) = 4.959,  
p < 0.05
ACE — angiotensin converting enzyme; NS — non-significant; PWD — P-wave duration
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3-vessel disease. In the study population, 92 EST 
tests were described as ischemic. Among ischemic 
EST, we found 18 cases with angina pectoris, 
68 cases of horizontal or downsloping ST-seg-
ment depression, 7 cases of ST-segment in aVR, 
11 cases of exercise-induced ventricular arrhythmia, 
5 cases of exercise-induced hypotension, 3 cases 
of exercise-induced LBBB.
Analysis of the predictive value  
of EST parameters
There were no significant differences in rest-
ing PWD in both II and V5 leads between both the 
coronary stenosis and non-coronary stenosis study 
population. The recovery PWD and the change 
in PWD (DPWD) were higher in patients with 
coronary stenosis in both II and V5 leads (Table 1).
Sensitivity, specificity, positive predictive pow-
er (PPP), and negative predictive power (NPP) for 
each predictive parameter are presented in Table 2. 
The sensitivity and specificity for the isolated 
ST­segment depression analysis were 31% (25% 
in female, 42% in male) and 76% (63% in female, 
80% in male), respectively, and for ST­elevation 
in aVR 52% and 68%, respectively. However, 
elevation in aVR was described only in 7 cases 
of EST in men. The presence of a combination 
of ST-segment deviation with other EST-induced 
clinical and electrocardiographic abnormalities 
(such as exercise-induced chest pain, ventricular 
arrhythmia, hypotension, LBBB) increased the 
sensitivity of the test.
Abnormal recovery PWD in II and/or V5 lead 
(≥ 120 ms) had 55% (52% in female, 66% in male) 
sensitivity and 68% specificity. The combination of 
abnormal recovery PWD in II and/or V5 lead with 
ST-segment changes increased the test sensitiv-
ity in the diagnosis of significant CAD. Combined 
analysis of abnormal recovery PWD in II and/or 
V5 lead with ST-segment depression analysis and 
Table 2. Comparison of exercise stress test predictive factors in the overall study population and in  
respect of the presence of arterial hypertension in the medical history of patients and body mass index.
Predictive factor Sensitivity (%):  
female/male
Specificity (%):  
female/male
PPP (%):  
female/male
NPP (%):  
female/male
Overall study population
ST-segment deviation + other EST 
clinical and electrocardiographic  
abnormalities*
41 (51/37) 69 (63/72) 49 (49/47) 66 (66/61)
Recovery PWD in II and/or  
V5 lead ≥ 120 ms
55 (56/48) 68 (51/70) 43 (44/47) 65 (66/60)
Recovery PWD in II and/or  
V5 lead ≥ 120 ms + ST-segment 
deviation + other EST clinical  
and electrocardiographic  
abnormalities* 
83 (83/82) 20 (26/18) 42 (40/44) 63 (63/62)
Increase in DPWDII and/or DPWDV5 44 (42/45) 62 (60/63) 44 (42/46) 66 (60/62)
Increase in DPWDII and/or  
DPWDV5 + ST-segment deviation 
+ other EST clinical and  
electrocardiographic  
abnormalities*
69 (71/67) 42 (40/42) 45 (45/45) 66 (68/65)
Predictive factor Sensitivity (%) Specificity (%) PPP (%) NPP (%)
Presence of arterial hypertension and abnormal body mass index
Recovery PWD in II  
and/or V5 lead ≥ 120 ms
49 59 40 67
Increase in DPWDII and/or DPWDV5 42 60 43 62
Population without arterial hypertension and abnormal body mass index
Recovery PWD in II and/or  
V5 lead ≥ 120 ms
63 91 83 77
Increase in DPWDII and/or DPWDV5 64 95 85 81
*Exercise-induced chest pain, ventricular arrhythmia, hypotension, left bundle branch block; EST — exercise stress test; NPP — negative pre-
dictive power; PPP — positive predictive power; PWD — P-wave duration
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other EST-induced abnormalities had the highest 
sensitivity, but in this case a spectacular decrease 
in specificity was observed.
An increase in DPWD (positive value of 
DPWD) was characterized by 44% sensitivity 
(42% in female, 45% in male) and 62% specificity 
(60% in female, 63% in male). The combination of 
the increase in DPWD in II and/or V5 leads with 
ST-segment depression and other EST-induced 
abnormalities (such as exercise-induced chest pain, 
ventricular arrhythmia, hypotension, LBBB) in-
creased the sensitivity of the test in the detection of 
the presence of significant coronary stenoses, espe-
cially in females (71% in females and 67% in males).
The sensitivity and specificity of the abnormal 
recovery PWD in II and/or V5 lead (≥ 120 ms) in the 
population with normal (non-ischemic) EST result 
was 20% and 76%, respectively (PPP 33%; NPP 
62%). The sensitivity and specificity of the increase 
in DPWD in II and/or V5 leads in the population with 
normal (non­ischemic) EST result was 67% and 
13%, respectively (PPP 10%; NPP 71%).
Analysis of the predictive value of DPWD  
in II and/or V5 and the extent of CAD
An analysis of the predictive value of PWDII, 
PWDV5 with reference to the extent of CAD re-
vealed higher sensitivity and specificity of the 
increase in DPWD in II and/or V5 for left CAD: 69% 
and 47%, respectively (PPP 79%, NPP 56%). The 
sensitivity and specificity of the increase in DPWD 
in II and/or V5 for the right coronary artery was 
35% and 56%, respectively (PPP 37%, NPP 57%).
The sensitivity and specificity of abnormal 
recovery PWD in II and/or V5 for the left coronary 
artery was 39% and 65%, respectively (PPP 45%, 
NPP 64%), and for the right coronary artery 31% 
and 67%, respectively (PPP 44%, NPP 60%).
The sensitivity and specificity of the increase 
DPWD in II and/or V5 for 1­vessel CAD was 31% 
and 66% (PPP 29%, NPP 67%), respectively; for 
2­vessel CAD 47% and 63% (PPP 49%, NPP 59%), 
respectively, and for 3­vessel CAD 70% and 50% 
(PPP 65%, NPP 58%), respectively.
Analysis of resting and recovery PWD  
— correlation with BMI, the presence  
of arterial hypertension and LV hypertrophy
The majority of the study population had ab-
normal BMI (BMI ≥ 25 kg/m2, n = 218; p < 0.001) 
and the medical history of arterial hypertension 
(n = 144; p < 0.001). The dispersion of increased 
BMI and arterial hypertension were similar in all the 
study groups (Table 1). An analysis of the results in 
the study subgroups revealed a positive correlation 
between BMI and resting PWDII and PWDV5 values 
prior to the EST (r = 0.266, p < 0.01; r = 0.251, 
p < 0.05, respectively) (Fig. 1). There was a cor-
relation between the presence of arterial hyper-
tension in the medical history of the patients and 
PWD (Fig. 2). In hypertensive patients, the resting 
PWDII was higher (115 ± 1.65 ms) in comparison 
with non-hypertensive patients (106 ± 1.65 ms; 
p < 0.001). EST increased PWDII and PWDV5 in 
both hypertensive and non-hypertensive patients. 
In hypertensive patients, recovery PWDII was 
higher (122 ± 1.70 ms) in comparison with non-
hypertensive patients (113 ± 1.67 ms; p < 0.001). 
Also, a significant difference in the prolongation 
of recovery PWD between hypertensive (119 ± 
± 1.71 ms) and non-hypertensive patients (110 ± 
± 1.73 ms; p < 0.01) was observed in lead V5. 
There were no differences in respect of the pres-
ence of arterial hypertension in DPWD in lead II. 
DPWDV5 was higher in hypertensive patients (7.49 ± 
± 1.30 ms vs. 5.16 ± 1.14 ms; p < 0.05).
The presence of abnormal BMI and arterial 
hypertension influenced also the prognostic value 
of prolonged recovery PWD and the increase in 
DPWD in leads II and/or V5. In the population 
with arterial hypertension and abnormal BMI, 
sensitivity and specificity of abnormally prolonged 
recovery PWD (≥ 120 ms) in leads II and/or V5 
was 49% and 59%, respectively. In the population 
without arterial hypertension and with normal 
BMI, prolonged recovery PWD (≥ 120 ms) dur-
ing EST was described with 63% sensitivity and 
91% specificity and had 83% PPP and 77% NPP, 
respectively. In the group of patients with both ar-
terial hypertension and abnormal BMI, sensitivity 
and specificity of increased DPWD in leads II and/
or V5 was 42% and 60%, respectively. In the study 
population without arterial hypertension and with 
normal BMI, sensitivity of increase in DPWD in 
leads II and/or V5 was 64% with specificity up to 
95% (PPP 85% and NPP 81%) (Table 2).
Discussion
The results of the study: 1) show low sensitiv-
ity of significant coronary occlusions identification 
by an analysis of isolated ST-segment deviation 
during EST; 2) indicate that the addition of an 
analysis of the increase in DPWD or prolonged 
PWD (≥ 120 ms) in leads II and/or V5 to ST-
-segment changes and other electrocardiographic 
and clinical abnormalities observed during exer-
cise stress tests (such as exercise-induced chest 
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pain, ventricular arrhythmia, hypotension, LBBB) 
increases sensitivity of the exercise stress test in 
the detection of significant coronary occlusions; 
3) show higher sensitivity and specificity of the 
increase in DPWD in leads II and/or V5 for left CAD 
and 3­vessel CAD. The present study, for the first 
time, provides evidence for the negative influence 
of the presence of arterial hypertension and, to 
a lesser extent, of the presence of abnormal BMI on 
the predictive value of P-wave changes during EST.
Results obtained in the present observation 
are consistent with the results of the study by 
Maganis et al. [18], where a combination of DPWDV5 
with ST-segment deviation increased sensitivity of 
EST in identification of myocardial ischemia from 
34% (for ST­segment based evaluation of EST) 
to 79%. Maganis et al. [18] calculated that DPWD 
≥ 20 ms correlated with myocardial ischemia, where- 
as in our study DPWD ≥ 20 ms was described in none 
of the cases of angiographically documented sub-
stantial coronary atherosclerosis. Moreover, most 
of the population of our study with angiographically 
documented significant coronary lesions had 2­ or 
3-vessel disease. According to the methodological 
postulates used in the present study, sensitivity 
of EST increased from 31% (ST­segment based 
Figure 1. Univariate correlation (Pearson correlation) between body mass index (BMI) and resting PWDII, PWDV5 (A, B), 
recovery PWDII, PWDV5 (C, D), DPWDII and DPWDV5 (E, F); PWD — P-wave duration; NS — non-significant.
Figure 2. The relation between the presence of arterial hypertension (AH) in the medical history of patients and resting (A) 
PWDII and PWDV5 and recovery (B) PWDII and PWDV5 values; means ± standard errors are shown; PWD — P-wave 
duration;*p < 0.05; **p < 0.01; ***p < 0.001.
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interpretation of EST) to 69%. Maganis et al. [18] 
evaluated the presence of ischemia in stress single-
photon emission computed tomography (SPECT), 
while we related EST interpretation to coronary an-
giography results. The value of prolonged P-wave 
with EST in patients, who underwent coronary 
angiography, was also discussed by Myrianthefs et 
al. [15]. Nevertheless, the group of patients with 
significant CAD in this study was relatively small, 
the control group included some healthy volunteers 
and the incidence of comorbidities, such as arte-
rial hypertension and obesity were not analyzed. 
Therefore, it is possible that higher intergroup 
difference in PWD could result from heterogeneity 
of the study groups. In our study, all groups were 
homogenous, so the obtained results were not 
affected by comorbidities other than significant 
CAD. Despite the high sensitivity (with dramatic 
decrease in specificity) of the combination of pro-
longed (≥ 120 ms) recovery PWD with other EST 
diagnostic criteria, we would rather advise DPWD 
analysis in the interpretation of EST. Moreover, 
in our observations, we noticed many cases of 
patients with abnormal resting PWD, who had 
decreased PWD on EST, but recovery PWD still 
remained abnormal.
In the present study, we also confirm the 
uncertain value of EST evaluation by isolated ST- 
-segment deviations. Low sensitivity of ST-segment 
depression in V4–V6 has been described before [19, 
20]. ST-segment deviations were found to have 
limited predictive value in CAD in women [21, 22].
Recent observations confirm the hypothesis 
that increased LV filling pressure (due to myo-
cardial ischemia/damage, the presence of arterial 
hypertension, increased blood volume in the case 
of overweight/obesity) affects P-wave morphology 
in resting electrocardiography [8–10]. In our study, 
we found higher prognostic value of the increase 
in DPWD in leads II and/or V5 for detection of left 
coronary artery stenosis (vs. right coronary ar-
tery). Moreover, the sensitivity and specificity of 
PWD in both II and V5 increased with the number 
of coronary artery stenoses and was the highest 
for 3-vessel CAD. In the context of these results, 
we may support earlier hypotheses that PWD 
changes correlate with the severity of CAD [13] 
and with a rise in the LV filling pressure, as a result 
of myocardial ischemia [23]. In the classical model 
of myocardial ischemia cascade, angina symptoms 
are preceded by depolarization and repolarization 
changes on the electrocardiogram, which in turn 
are preceded by LV diastolic dysfunction from 
myocardial ischemia [24]. LV diastolic dysfunction 
results in the increase in the LV filling pressure, 
which subsequently may increase left atrial pres-
sure and/or diameter [25].
In the population of our study, the presence of 
overweight and obesity was similar in both groups. 
It should be noted, though, that in the present 
investigation, an increase in BMI also correlated 
with resting but did not affect recovery PWD.
In our study, we found a correlation between 
the presence of arterial hypertension in the medi-
cal history of patients and both the resting and 
recovery PWD. Dagli et al. [25] reported that 
resting PWD may be a good indicator for heart 
remodeling in hypertension as there is a correla-
tion between high blood pressure, LV hypertrophy, 
diastolic dysfunction and increased volume of the 
left atrium. It was reported that P-wave morphol-
ogy changes may result from left or right atrial 
hypertrophy and/or dilatation [26]. It is well known 
that physical exercise results in volume overload 
of both atria and ventricles. We expected that in-
creased blood volume during exercise would change 
the sensitivity of P-wave changes in the diagnosis 
of CAD in the population of patients with arterial 
hypertension-related atrial volume or intra-atrial 
pressure changes. Regardless of the presence of 
hypertension, changes of PWD with EST still re-
main a good indicator of significant CAD.
Limitations of the study
Our study has some limitations. During the 
acquisition of the data from EST, both observ-
ers were blinded to the result of the test. That is 
the reason for the small sample of ischemic EST. 
However, it should be noted that all the patients 
underwent stress test during hospitalization. Most 
of the tests were submaximal due to treatment 
with beta-blockers and the general condition of 
the inpatients. The observers were not involved in 
the process of qualification neither for EST nor for 
coronary angiography. Also, both EST and coronary 
angiography were provided from 2009 to 2011, 
before the publication of the current guidelines on 
the management of stable CAD.
Conclusions
In conclusion, an analysis of the changes of 
PWD should be introduced into standard interpre-
tation of exercise stress test as it has been shown 
to be a useful electrocardiographic tool in the 
prognosis of significant coronary lesions due to the 
increase of sensitivity in detection of the disease. 
Our study also brought out the problem of low 
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sensitivity of ST-segment deviation-based EST-
-interpretation. According to the growing number 
of data suggesting the prognostic and diagnostic 
utility of PWD and the variable prognostic value of 
ST-segment deviations during EST in the diagnosis 
of CAD, novel specific criteria for clinical applica-
tion in EST should be discussed and established.
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